Papers: 10.1186/s13075-015-0651-0

https://doi.org/10.1186/s13075-015-0651-0

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Cited by: 127
Author(s): Maarten Van Roy, Cedric Ververken, Els Beirnaert, Sven Hoefman, Joost A. Kolkman, Michel Vierboom, Elia Breedveld, Bert ‘t Hart, Sofie Poelmans, Lieselot Bontinck, Alex Hemeryck, S. Jacobs, Judith Baumeister, Hans Ulrichts
Published: over 11 years ago

Software Mentions 1